AnHui Longcom Biologic Pharmacy Co., Ltd. (Longcom), located in the National New and High Technology Industrial Development Zone , Hefei, AnHui province，P. R. China, is invested by Guozhen Group and State Development & Investment Corp. , with a registered capital of RMB 33 million yuan.
AnHui Longcom Biologic Pharmacy Co., Ltd., is main engaged in research, development and marketing of biological products for health care. The company possesses manufacturing and quality control facilities conforming Good Manufacturing Practice (GMP) Standard approved by State Food and Drug Administration of China (SFDA) in 2000. (GMP Certificate, B0483)
Vaccae is lyophilized heat-killed Mycobacterium vaccae vaccine for injection indicated for treatment of patients with pulmonary tuberculosis. Vaccae was co-developed by National Institute for the Control of Drugs and Biological Products, 309 Hospital of PLA, and Anhui Longcom Biologic Pharmacy Co.,Ltd. SFDA of China approved Vaccae in January 2001. (Licence Number, GuoYaoZhunZi S20010003)